NeoGenomics, Inc. (NG9)
XSTU
14.25
+0.02 (+0.11%)
Closed
Oct 8, 2026
Day's Range
13.7714.25
52 wk Range
6.1517.81
Financial Statements - NG9 - NeoGenomics, Inc.
Revenue
727.33M▲ 30.1%
Net Income
-108.02M▼ 62.1%Net Margin -14.9%
EBITDA
-10.93M▼ 351.0%
Free Cash Flow
-21.77M▲ 24.4%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 727.33M | 559.23M | 591.64M | 509.72M | 484.32M | 444.44M |
| Cost of Goods | 413.03M | 313.63M | 347.03M | 321.83M | 297.26M | 258.55M |
| Gross Profit | 314.29M | 245.59M | 244.60M | 187.89M | 187.06M | 185.89M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -88.12M | -72.34M | -96.64M | -153.10M | -118.75M | -13.99M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -27.45M | -5.95M | -10.44M | -4.72M | 108.76M | 6.95M |
| Pre Tax Income | -110.26M | -68.29M | -97.09M | -159.34M | -15.07M | -14.05M |
| Income Tax | -2.24M | -1.65M | -9.12M | -15.09M | -6.72M | -18.22M |
| Net Income | -108.02M | -66.64M | -87.96M | -144.25M | -8.34M | 4.17M |
| EPS Basic | -0.84 | -0.62 | -0.7 | -1.16 | -0.07 | 0.04 |
| EPS Diluted | -0.84 | -0.62 | -0.7 | -1.16 | -0.07 | 0.04 |
| Basic Shares Outstanding | 128.10M | 107.22M | 130.61M | 129.27M | 124.84M | 113M |
| Diluted Shares Outstanding | 128.10M | 107.22M | 130.61M | 129.27M | 124.84M | 113M |
| Ebit | -106.51M | -62.69M | -90.19M | -151.76M | -6.85M | -7.03M |
| Ebitda | -10.93M | 4.35M | -6.51M | -77.81M | 46.49M | 33.59M |
| Net Income Continuous Operations | -108.02M | -66.64M | -87.96M | -144.25M | -8.34M | 4.17M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
